*仅供医学专业人士阅读参考
强直诊疗之路,我们携手并进。
参考文献:
[1]王辰, 王建安. 内科学(八年制第3版)[M]. 北京:人民卫生出版社, 2015:1181.
[2]Zochling J, van der Heijde D, Burgos-Vargas R, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis[J]. Ann Rheum Dis. 2006, 65(4):442-52.
[3]Ward MM,Deodhar A,Akl EA, et al.American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis[J]. Arthritis Rheumatol. 2016, 68(2):282-98.
[4]van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis[J]. Ann Rheum Dis. 2017, 76(6):978-991.
[5]Ward MM, Deodhar A, Gensler LS, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis[J]. Arthritis Rheumatol. 2019, 71(10):1599-1613.
[6]Zhu W, He X, Cheng K, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments[J]. Bone Res. 2019, 7:22.
[7]裘影影, 汤郁, 芮金兵, 等. 艾拉莫德治疗难治性强直性脊柱炎临床效果观察[J]. 江苏大学学报(医学版). 2016, 26(3):235-239.
[8]曾惠琼, 孔卫红, 庄鹏, 等. 艾拉莫德治疗强直性脊柱炎疗效观察[J]. 海南医学. 2016, 27(1): 118-120.
[9]Luo Y, Zheng N, Wu R. Is iguratimod effective in refractory axial spondyloarthritis[J].Scand J Rheumatol. 2018, 47(6):518-520.
[10]黄帮君, 马进兴. 艾拉莫德治疗强直性脊柱炎短期疗效观察[J]. 中国社区医师. 2018, 34(13): 92-93.
[11]林玉萍, 刘红, 高锦团. 艾拉莫德治疗强直性脊柱炎的初步观察[J]. 临床合理用药. 2019, 12(5): 9-13.
[12]许百洁, 莫守崎, 薛晓倩, 等. 艾拉莫德治疗强直性脊柱炎的疗效和安全性研究[J]. 新医学. 2019, 50(12): 915-918.
[13] 王中立 , 戴建国 , 侍昊 , 等. 恐惧, 焦虑, 抑郁情绪对小鼠机械性痛阈的影响[J]. 东南大学学报(医学版). 2016, 35(02): 186-188.
[14]Millner JR, Barron JS, Beinke KM, et al. Exercise for ankylosing spondylitis: An evidence-based consensus statement[J]. Semin Arthritis Rheum. 2016, 45(4):411-27.